| References |
|
|
Ashley RL
(1998)
Genital herpes. Type-specific antibodies for diagnosis and management.
Dermatologic Clinics
16:
789–793.
|
|
|
Ashley RL,
Wu L,
Pickering JW,
Tu MC and
Schnorenberg L
(1998)
Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.
Journal of Clinical Microbiology
36:
294–295.
|
|
|
Bacon TH,
Levin MJ,
Leary JJ,
Sarisky RT and
Sutton D
(2003)
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.
Clinical Microbiological Reviews
16:
114–128.
|
|
|
Benedetti J,
Corey L and
Ashley R
(1994)
Recurrence rates in genital herpes after symptomatic first-episode infection.
Annals of Internal Medicine
121:
847–854.
|
|
|
Bloom DC
(2004)
HSV LAT and neuronal survival.
International Reviews of Immunology
23:
187–198.
|
|
|
Bryson Y,
Dillon M,
Bernstein DI et al.
(1993)
Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study.
Journal of Infectious Diseases
167:
942–946.
|
|
|
Cernik C,
Gallina K and
Brodell RT
(2008)
The treatment of herpes simplex infections: an evidence-based review.
Archives of Internal Medicine
168:
1137–1144.
|
|
|
Cone RW,
Hobson AC,
Brown Z et al.
(1994)
Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women.
JAMA
272:
792–796.
|
|
|
Corey L
(1982)
The diagnosis and treatment of genital herpes.
JAMA
248:
1041–1049.
|
|
|
Corey L,
Adams HG,
Brown ZA and
Holmes KK
(1983)
Genital herpes simplex virus infections: clinical manifestations, course, and complications.
Annals of Internal Medicine
98:
958–972.
|
|
|
Corey L and
Ashley R
(2004)
Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
Herpes
11(suppl. 3):
170A–174A.
|
|
|
Corey L,
Bodsworth N,
Mindel A et al.
(2007)
An update on short-course episodic and prevention therapies for herpes genitalis.
Herpes
14(suppl. 1):
5A–11A.
|
|
|
Corey L,
Wald A,
Celum CL and
Quinn TC
(2004)
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.
Journal of Acquired Immune Deficiency Syndrome
35:
435–445.
|
|
|
Cowan FM,
Copas A,
Johnson AM et al.
(2002)
Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence?
Sexually Transmitted Infections
78:
346–348.
|
|
|
Decman V,
Freeman ML,
Kinchington PR and
Hendricks RL
(2005)
Immune control of HSV-1 latency.
Viral Immunology
18:
466–473.
|
|
|
Engelberg R,
Carrell D,
Krantz E,
Corey L and
Wald A
(2003)
Natural history of genital herpes simplex virus type 1 infection.
Sexually Transmitted Diseases
30:
174–177.
|
|
|
Espy MJ,
Uhl JR,
Sloan LM et al.
(2006)
Real-time PCR in clinical microbiology: applications for routine laboratory testing.
Clinical Microbiology Reviews
19:
165–256.
|
|
|
Fleming DT,
McQuillan GM,
Johnson RE et al.
(1997)
Herpes simplex virus type 2 in the United States, 1976 to 1994.
New England Journal of Medicine
337:
1105–1111.
|
|
|
Gibson JJ,
Hornung CA,
Alexander GR et al.
(1990)
A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection.
Journal of Infectious Diseases
162:
306–312.
|
|
|
Gleaves CA,
Wilson DJ,
Wold AD and
Smith TF
(1985)
Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation.
Journal of Clinical Microbiology
21:
29–32.
|
|
|
Grunewald K,
Desai P,
Winkler DC et al.
(2003)
Three-dimensional structure of herpes simplex virus from cryo-electron tomography.
Science
302:
1396–1398.
|
|
|
Harel L,
Smetana Z,
Prais D et al.
(2004)
Presence of viremia in patients with primary herpetic gingivostomatitis.
Clinical Infectious Diseases
39:
636–640.
|
|
|
Kimberlin DW
(2004)
Neonatal herpes simplex infection.
Clinical Microbiology Reviews
17:
1–13.
|
|
|
book
Knipe DM and
Howley MH
(2007)
Fields Virology,
pp. 2515–2534.
Philadelphia: Lippincott Williams & Wilkins.
|
|
|
Koelle DM,
Benedetti J,
Langenberg A and
Corey L
(1992)
Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.
Annals Internal Medicine
116:
433–437.
|
|
|
Koelle DM and
Corey L
(2008)
Herpes simplex: insights on pathogenesis and possible vaccines.
Annual Reviews Medicine
59:
381–395.
|
|
|
Kohl S
(1982)
Human immune response to herpes simplex virus.
Journal of Infectious Diseases
146:
292.
|
|
|
Kohl S and
Ericsson CD
(1982)
Cellular cytotoxicity to herpes simplex virus-infected cells of leukocytes from patients with serious burns.
Clinical Immunology and Immunopathology
24:
171–178.
|
|
|
Lafferty WE,
Coombs RW,
Benedetti J,
Critchlow C and
Corey L
(1987)
Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.
New England Journal of Medicine
316:
1444–1449.
|
|
|
Lakeman FD and
Whitley RJ
(1995)
Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Journal of Infectious Diseases
171:
857–863.
|
|
|
Lebrun-Vignes B,
Bouzamondo A,
Dupuy A et al.
(2007)
A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
Journal of the American Academy of Dermatology
57:
238–246.
|
|
|
Lipson SM,
Salo RJ and
Leonardi GP
(1991)
Evaluation of five monoclonal antibody-based kits or reagents for the identification and culture confirmation of herpes simplex virus.
Journal of Clinical Microbiology
29:
466–469.
|
|
|
Lisco A and
Vanpouille C
(2008)
HSV-2 suppression and the incidence of HIV.
New England Journal of Medicine
359:
535.
|
|
|
Mikloska Z,
Sanna PP and
Cunningham AL
(1999)
Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.
Journal of Virology
73:
5934–5944.
|
|
|
Nahmias AJ,
Josey WE,
Naib ZM et al.
(1971)
Perinatal risk associated with maternal genital herpes simplex virus infection.
American Journal of Obstetrics and Gynecology
110:
825–837.
|
|
|
Nahmias AJ,
Lee FK and
Beckman-Nahmias S
(1990)
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
Scandinavian Journal of Infectious Diseases. Supplementum
69:
19–36.
|
|
|
Parvey LS and
Ch'ien LT
(1980)
Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes.
Pediatrics
65:
1150–1153.
|
|
|
Rupp R and
Bernstein DI
(2008)
The potential impact of a prophylactic herpes simplex vaccine.
Expert Opinion on Emerging Drugs
13:
41–52.
|
|
|
Ryan C and
Kinghorn G
(2006)
Clinical assessment of assays for diagnosis of herpes simplex infection.
Expert Review of Molecular Diagnostics
6:
767–775.
|
|
|
Safrin S,
Ashley R,
Houlihan C,
Cusick PS and
Mills J
(1991)
Clinical and serologic features of herpes simplex virus infection in patients with AIDS.
AIDS
5:
1107–1110.
|
|
|
Sauerbrei A and
Wutzler P
(2007)
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections.
Medical Microbiology and Immunology
196:
95–102.
|
|
|
Skoldenberg B,
Forsgren M,
Alestig K et al.
(1984)
Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.
Lancet
2:
707–711.
|
|
|
Spruance SL,
Overall JC Jr.,
Kern ER et al.
(1977)
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
New England Journal of Medicine
297:
69–75.
|
|
|
Stanberry LR,
Spruance SL,
Cunningham AL et al.
(2002)
Glycoprotein-d-adjuvant vaccine to prevent genital herpes.
New England Journal of Medicine
347:
1652–1661.
|
|
|
Stevens JG and
Cook ML
(1971)
Latent herpes simplex virus in spinal ganglia of mice.
Science
173:
843–845.
|
|
|
Wald A and
Corey L
(2003)
How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?
Journal of Infectious Diseases
187:
1509–1512.
|
|
|
Whitley R,
Lakeman AD,
Nahmias A and
Roizman B
(1982)
Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.
New England Journal of Medicine
307:
1060–1062.
|
|
|
Whitley RJ and
Lakeman F
(1995)
Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations.
Clinical Infectious Diseases
20:
414–420.
|
|
|
Whitley RJ,
Spruance S,
Hayden FG et al.
(1984)
Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host.
Journal of Infectious Diseases
149:
1–8.
|
|
|
Xu F,
Sternberg MR,
Kottiri BJ et al.
(2006)
Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.
JAMA
296:
964–973.
|
| Further Reading |
|
|
Celum C,
Wald A,
Hughes J et al.
(2008)
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
Lancet
371(9630):
2109–2119. 21 June.
|
|
|
Kimberlin DW
(2008)
When should you initiate acyclovir therapy in a neonate?
The Journal of Pediatrics
153(2):
155–156. August.
|
|
|
other
Linssen CF,
Jacobs JA,
Stelma FF et al.
(2008) Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Medicine (forthcoming). 5 August.
|
|
|
Mark KE,
Wald A,
Magaret AS et al.
(2008)
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.
The Journal of Infectious Diseases
198(8):
1141–1149. 15 October.
|
|
|
Mertz GJ
(2008)
Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission.
The Journal of Infectious Diseases
198(8):
1098–1100. 15 Octobor.
|
|
|
Nagot N,
Ouedraogo A,
Foulongne V et al.
(2007)
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
The New England Journal of Medicine
356(8):
790–799. 22 February.
|
|
|
Philip SS,
Ahrens K,
Shayevich C et al.
(2008)
Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection.
Clinical Infectious Diseases
47(10):
e79–e82. 15 November.
|
|
|
Tran T,
Druce JD,
Catton MC,
Kelly H and
Birch CJ
(2004)
Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003.
Sexually Transmitted Infections
80(4):
277–279. August.
|
|
|
Xu F,
Gee JM,
Naleway A et al.
(2008)
Incidence of neonatal herpes simplex virus infections in two managed care organizations: implications for surveillance.
Sexually Transmitted Diseases
35(6):
592–598. June.
|
